Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$14.42 - $21.39 $16.8 Million - $24.9 Million
-1,162,500 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$16.56 - $18.94 $8.33 Million - $9.53 Million
-502,949 Reduced 30.2%
1,162,500 $20.2 Million
Q3 2020

Nov 16, 2020

SELL
$17.41 - $19.89 $6.26 Million - $7.16 Million
-359,826 Reduced 17.77%
1,665,449 $30.5 Million
Q2 2020

Aug 14, 2020

BUY
$14.43 - $19.16 $1.09 Million - $1.44 Million
75,275 Added 3.86%
2,025,275 $36.2 Million
Q4 2019

Feb 14, 2020

BUY
$16.33 - $21.37 $1.14 Million - $1.5 Million
70,000 Added 3.72%
1,950,000 $35.1 Million
Q2 2019

Aug 14, 2019

BUY
$13.1 - $22.1 $15.9 Million - $26.7 Million
1,210,000 Added 180.6%
1,880,000 $41.5 Million
Q3 2018

Nov 14, 2018

SELL
$14.45 - $20.25 $289,000 - $405,000
-20,000 Reduced 2.9%
670,000 $11.1 Million
Q2 2018

Aug 14, 2018

SELL
$10.25 - $17.45 $51,250 - $87,250
-5,000 Reduced 0.72%
690,000 $9.66 Million
Q1 2018

May 15, 2018

BUY
$9.1 - $13.7 $596,050 - $897,350
65,500 Added 10.41%
695,000 $7.68 Million
Q4 2017

Feb 14, 2018

SELL
$8.35 - $14.4 $74,315 - $128,160
-8,900 Reduced 1.39%
629,500 $5.54 Million
Q3 2017

Nov 14, 2017

BUY
$11.1 - $14.5 $7.09 Million - $9.26 Million
638,400
638,400 $8.52 Million

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $96.4M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.